Cargando…

Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders

Alpha-synuclein (aSyn) is a pre-synaptic monomeric protein that can form aggregates in neurons in Parkinson’s disease (PD), Parkinson’s disease with dementia (PDD) and dementia with Lewy bodies (DLB), and in oligodendrocytes in multiple system atrophy (MSA). Although aSyn in astrocytes has previousl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Altay, Melek Firat, Liu, Alan King Lun, Holton, Janice L., Parkkinen, Laura, Lashuel, Hilal A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652889/ https://www.ncbi.nlm.nih.gov/pubmed/36371251 http://dx.doi.org/10.1186/s40478-022-01468-8

Ejemplares similares

Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson’s Disease and Multiple System Atrophy
por: Sonustun, Berkiye, et al.
Publicado: (2022)

Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity
por: Lashuel, Hilal A., et al.
Publicado: (2022)

Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies
por: Magalhães, Pedro, et al.
Publicado: (2022)

Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders
por: Manzanza, Nelson de Oliveira, et al.
Publicado: (2021)

Alpha-synuclein biology in Lewy body diseases
por: Kim, Woojin Scott, et al.
Publicado: (2014)

Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson’s Disease
por: Cardinale, Antonella, et al.
Publicado: (2021)

The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration
por: Mahul-Mellier, Anne-Laure, et al.
Publicado: (2020)

Photobiomodulation Suppresses Alpha-Synuclein-Induced Toxicity in an AAV-Based Rat Genetic Model of Parkinson’s Disease
por: Oueslati, Abid, et al.
Publicado: (2015)

Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes
por: Gustafsson, Gabriel, et al.
Publicado: (2017)

Alpha-synuclein mRNA expression in oligodendrocytes in MSA
por: Asi, Yasmine T, et al.
Publicado: (2014)

Alpha-synuclein stimulation of astrocytes: Potential role for neuroinflammation and neuroprotection
por: Lee, He-Jin, et al.
Publicado: (2010)

Protein Clearance Mechanisms of Alpha-Synuclein and Amyloid-Beta in Lewy Body Disorders
por: Deleidi, Michela, et al.
Publicado: (2012)

Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies
por: Koss, David J., et al.
Publicado: (2022)

Unveiling transient protein-protein interactions that modulate inhibition of alpha-synuclein aggregation by beta-synuclein, a pre-synaptic protein that co-localizes with alpha-synuclein
por: Janowska, Maria K., et al.
Publicado: (2015)

Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson’s disease
por: Swirski, Marta, et al.
Publicado: (2014)

The Synucleins and the Astrocyte
por: Myers, Abigail J., et al.
Publicado: (2023)

Monitoring alpha‐synuclein oligomerization and aggregation using bimolecular fluorescence complementation assays: What you see is not always what you get
por: Frey, Bryan, et al.
Publicado: (2020)

Human Astrocytes Transfer Aggregated Alpha-Synuclein via Tunneling Nanotubes
por: Rostami, Jinar, et al.
Publicado: (2017)

Extracellular Alpha-Synuclein Promotes a Neuroinhibitory Secretory Phenotype in Astrocytes
por: Di Marco Vieira, Bruno, et al.
Publicado: (2020)

Evaluation of alpha-synuclein immunohistochemical methods for the detection of Lewy-type synucleinopathy in gastrointestinal biopsies
por: Corbillé, Anne-Gaëlle, et al.
Publicado: (2016)

Alpha-Synuclein Oligomers—Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body Disorders
por: Ingelsson, Martin
Publicado: (2016)

The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders
por: Irwin, David J., et al.
Publicado: (2018)

Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies
por: Perra, Daniela, et al.
Publicado: (2021)

Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease
por: Sekiya, Hiroaki, et al.
Publicado: (2022)

Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue
por: Dhavale, Dhruva D., et al.
Publicado: (2023)

Absence of Alpha-Synuclein Pathology in the Stomach of a Patient With Prodromal Dementia With Lewy Bodies
por: Shin, Chaewon, et al.
Publicado: (2023)

Comparative Analysis of Total Alpha-Synuclein (αSYN) Immunoassays Reveals That They Do Not Capture the Diversity of Modified αSYN Proteoforms
por: Petricca, Lara, et al.
Publicado: (2022)

Extent of N-terminus exposure of monomeric alpha-synuclein determines its aggregation propensity
por: Stephens, Amberley D., et al.
Publicado: (2020)

Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration
por: Duffy, Megan F., et al.
Publicado: (2018)

Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression
por: Sorrentino, Zachary A., et al.
Publicado: (2019)

Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies
por: Fairfoul, Graham, et al.
Publicado: (2016)

Uptake and mitochondrial dysfunction of alpha-synuclein in human astrocytes, cortical neurons and fibroblasts
por: Braidy, Nady, et al.
Publicado: (2013)

Hepcidin-to-Ferritin Ratio Is Decreased in Astrocytes With Extracellular Alpha-Synuclein and Iron Exposure
por: Cui, Juntao, et al.
Publicado: (2020)

A simple, versatile and robust centrifugation‐based filtration protocol for the isolation and quantification of α‐synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in α‐synuclein research
por: Kumar, Senthil T., et al.
Publicado: (2020)

Phospho-S129 Alpha-Synuclein Is Present in Human Plasma but Not in Cerebrospinal Fluid as Determined by an Ultrasensitive Immunoassay
por: Cariulo, Cristina, et al.
Publicado: (2019)

Unraveling the Complex Interplay between Alpha-Synuclein and Epigenetic Modification
por: Sugeno, Naoto, et al.
Publicado: (2023)

Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
por: Masliah, Eliezer, et al.
Publicado: (2011)

Correction to: Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration
por: Duffy, Megan F., et al.
Publicado: (2018)

Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders
por: Schaser, Allison J., et al.
Publicado: (2019)

Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
por: Marotta, Nicholas P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vgfmjpk0a7fe2vp0aa8h8gpalo